Clinical Trials
9
Active:5
Completed:0
Trial Phases
2 Phases
Phase 1:5
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (55.6%)Phase 2
4 (44.4%)Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients.
Phase 2
Recruiting
- Conditions
- Intensive Care UnitCoronary Artery Bypass Grafting (CABG)High Risk PatientsCardiopulmonary BypassElective Cardiac SurgeryValvular Heart SurgeryMultiple Valve SurgeriesCombined Cardiac ProceduresAortic Surgical Procedures
- Interventions
- Drug: Intravenous 0.9% Sodium Chloride
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- GCP-Service International West GmbH
- Target Recruit Count
- 120
- Registration Number
- NCT06279793
- Locations
- 🇩🇪
University Hospital Augsburg, Augsburg, Germany
🇩🇪Charité Universitätsmedizin Berlin, Berlin, Germany
🇩🇪University of Bonn, Bonn, Germany
A phase II, open-label, multicenter study of orally administered RVU120 for the treatment of anemia in patients with lower-risk myelodysplastic neoplasms (MDS)
Phase 2
Active, not recruiting
- Conditions
- Anemia in patients with very low, low or intermediate risk myelodysplastic neoplasms (MDS)
- First Posted Date
- 2024-07-08
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- GCP-Service International West GmbH
- Target Recruit Count
- 45
- Registration Number
- 2023-509947-29-00
- Locations
- 🇩🇪
Universitaet Leipzig, Leipzig, Germany
🇩🇪Marien Hospital Duesseldorf GmbH, Duesseldorf, Germany
🇫🇷Hopital Saint Louis, Paris, France
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
Phase 2
Active, not recruiting
- Conditions
- Myelodysplastic SyndromesAcute Myeloid Leukemia
- Interventions
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- GCP-Service International West GmbH
- Target Recruit Count
- 46
- Registration Number
- NCT05583552
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, Australia
🇦🇺Royal Brisbane and Women's Hospitals, Brisbane, Australia
🇦🇺Linear Clinical Research, Nedlands, Australia
News
No news found